ToConceive Offers Hope to Couples Struggling with Infertility
New product from ToConceive provides couples dealing with infertility an increased chance of conception by promoting and increasing a woman's natural conception lubrication.
(PRWEB) January 23, 2013
For many couples, the path to having a baby can be full of many bumps, twists and turns. Oftentimes, couples cursed with infertility believe their only hope is expensive and complicated methods like in-vitro fertilization. A new product to the market, ToConceive, aims to change that mindset.
Discovered and developed by award-winning gynecologist Dr. Ronald Thompson, ToConceive is FDA-approved, easy-to-use and inexpensive. The science behind ToConceive is based on the 2010 Nobel Prize in Medicine for In-Vitro Fertilization and Sperm Capacitation.
"For over 30 years, I have attempted to help women achieve conception, pregnancy, and motherhood,” said Dr. Thompson. "ToConceive has already helped hundreds of women achieve conception, and now has the opportunity to help thousands of women worldwide to achieve conception, pregnancy, and motherhood."
According to the Center for Disease Control and Prevention, nearly 10 percent of women between the ages of 15 and 44 have fertility issues. Research has found that for a majority of the 6.1 million women dealing with infertility, the main issue is a lack of natural lubrication during intercourse. In 2003, the National Center for Health Statistics and the Centers for Disease Control and Prevention found that 75 percent of infertile women experience vaginal dryness and lubrication insufficiency.
Unlike over-the-counter lubrications, some of which actually contain spermicide and kill sperm, ToConceive is a topical lubrication clinically proven to increase Natural Conception Lubrication in a woman to aid in conception. The product concentrates on increasing a woman's natural conception lubrication to promote sperm capacitation. Essential to the conception process, sperm capacitation allows the sperm to travel the six or seven inches up the fallopian tube to penetrate and fertilize the egg.
Promoting in-vivo sperm capacitation, ToConceive also helps treat some types of male subfertility, such as anti-sperm antibodies caused by an infection in the prostate, insufficient numbers of sperm and abnormal sperm that prevents fertilization.
Available online through the ToConceive website (keytoconceive.com), ToConceive comes in a three-month supply for $150. The ToConceive website also contains background information on the science behind the product and numerous other resources and references for infertility.
ToConceive, LLC was established by Dr. Ronald Thompson, OBGYN and inventor of numerous gynecological products and methods. Dr. Thompson holds five United States patents, including fallopian tube and method of in vitro fertilization and embryo transfer, device for retrieval of ovum, embryo transfer arrangement, intrauterine delivery arrangement and in-vitro fertilization procedure using direct vision.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebtoconceive/launch/prweb10342077.htm